AXGN241115P12500
- 1.76
- +0.56+46.67%
AxoGen Newsroom
Top 10 Most Expensive Stocks (Only 1 Gets a Quant Sell)
Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript Summary
Insiders At Axogen Sold US$639k In Stock, Alluding To Potential Weakness
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $17
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
JMP Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $20
AxoGen | 10-Q: Q3 2024 Earnings Report
Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $18
Axogen Shares Are Trading Lower. The Company Reported Q3 Financial Results.
12 Health Care Stocks Moving In Thursday's Intraday Session
AxoGen: Q3 Earnings Snapshot
AxoGen Reports Strong Q3 2024 Revenue Growth
Earnings Flash (AXGN) AXOGEN Reports Q3 EPS $0.07
Express News | AxoGen Outlook FY Revenue USD 182-186 Million
Express News | AxoGen Q3 Gross Margin 74.9%
Express News | AxoGen Q3 Adjusted Ebitda USD 6.5 Million Vs. IBES Estimate USD 4.47 Million
Press Release: Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
Axogen 3Q Loss/Shr 4c >AXGN
Here's the Major Earnings Before the Open Tomorrow
Earnings Preview: AxoGen to Report Financial Results Pre-market on November 07
$AxoGen(AXGN.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $AxoGen(AXGN.US)$ to post revenue of USD46.98M for 2024Q3, up 13.82%